A University innovator who credits Venturefest Wales for spurring her decision to co-found a brand-new business returns to the one-day festival this week.
The first ever patient has been enrolled in the pivotal phase III clinical trial of a drug pioneered by Cardiff University which could bring hope for millions of shingles sufferers
A partnership which developed clinical wet wipes to tackle hospital 'superbug' infections has won a Business Innovation Prize at Cardiff University's Innovation and Impact Awards 2015, sponsored by leading law firm Geldards and IP Group.
The potential impact of a new cancer drug, designed to stop patients becoming resistant to common therapies in treating cancer of the lung, ovary, breast, colon and pancreas.
Dr David Houston and Mr James Blaxland (PHRMY), represented Cardiff University at the BBSRC Biotechnology Young Entrepreneurs Scheme regional competition.
